The present invention is directed to a compound of formula (I), or a pharmaceutically acceptable salt, solvate, hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR), such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases. ##STR00001##

 
Web www.patentalert.com

< Pyrazole compounds that modulate HSP90 activity

> Exendins and exendin agonists modified with albumin

> Corticotropin releasing factor 2 receptor agonists

~ 00554